BRIEF-Teva says it withdrew its marketing application for balugrastim from FDA review process last week
November 18, 2013 at 08:28 AM EST
Nov 18 (Reuters) - Teva Pharmaceutical Industries Ltd : * Announces updates to oncology biologic portfolio * Two additions to global oncology biologic portfolio with recent launches of
